Subjects and methods: The study was carried out on 71 patients with confirmed diagnosis of HCC were treated by radiofrequency ablation (RFA) with or without chemical embolization (TACE), assessment before and after treatment by CT / MRI and AFP, time from March 2020 to May 2021.